BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 14744837)

  • 1. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of statins on risk of stroke: a meta-analysis.
    Henyan NN; Riche DM; East HE; Gann PN
    Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
    Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
    J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system active medications and risk for fractures in older women.
    Ensrud KE; Blackwell T; Mangione CM; Bowman PJ; Bauer DC; Schwartz A; Hanlon JT; Nevitt MC; Whooley MA;
    Arch Intern Med; 2003 Apr; 163(8):949-57. PubMed ID: 12719205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women.
    Bakhireva LN; Shainline MR; Carter S; Robinson S; Beaton SJ; Nawarskas JJ; Gunter MJ
    Pharmacotherapy; 2010 Sep; 30(9):879-87. PubMed ID: 20795843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statin and bone metabolism].
    Osuga J
    Clin Calcium; 2004 Feb; 14(2):235-40. PubMed ID: 15576978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of statins on bone mineral density: a meta-analysis of clinical studies.
    Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
    Bone; 2007 Jun; 40(6):1581-7. PubMed ID: 17409043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the association between statin and fracture: a Bayesian consideration.
    Nguyen ND; Wang CY; Eisman JA; Nguyen TV
    Bone; 2007 Apr; 40(4):813-20. PubMed ID: 17178257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and fracture risk: study of a US veterans population.
    Scranton RE; Young M; Lawler E; Solomon D; Gagnon D; Gaziano JM
    Arch Intern Med; 2005 Sep; 165(17):2007-12. PubMed ID: 16186471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2006 Oct; 24(30):4808-17. PubMed ID: 17001070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group.
    Bauer DC; Orwoll ES; Fox KM; Vogt TM; Lane NE; Hochberg MC; Stone K; Nevitt MC
    J Bone Miner Res; 1996 Jan; 11(1):29-35. PubMed ID: 8770694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.
    Nichols R; Hopman WM; Morton AR; Harman GJ; Holden RM
    Hemodial Int; 2008 Apr; 12(2):275-9. PubMed ID: 18394063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
    Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
    J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial.
    Reid IR; Tonkin A; Cannon CP
    Bone; 2005 Aug; 37(2):190-1. PubMed ID: 15936996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
    Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT;
    Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.